Skip to main content

Full Schedule - Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!

Full Schedule - Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!

  • Wednesday, March 22, 2023
  • 8:45 AM – 10:00 AM
    (1) Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease
  • 10:30 AM – 11:45 AM
    (2) IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer Considerations
  • 10:30 AM – 11:45 AM
    (3) Federal Legislative and Regulatory Update
  • 10:30 AM – 11:45 AM
    (4) Measuring Medical Cost Offsets from Improvements in Medication Adherence Using Real-World Data
  • 10:30 AM – 11:45 AM
    (5) Challenges and Opportunities in Collecting Data to Address Health Disparities
  • 3:15 PM – 4:30 PM
    (6) Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management
  • 3:15 PM – 4:30 PM
    (7) AMCP Market Insights Best Practice: Strategies for Antibody-Drug Conjugates to Deliver Improved Patient Outcomes
  • 3:15 PM – 4:30 PM
    (8) Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research Agenda
  • 3:15 PM – 4:30 PM
    (9) The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications